EOM Pharmaceuticals Holdings
Financial ratios & Valuation

Historical Multiples (2012 – 2023)

2012 2013 2014 2015 2016 2017 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.14-5.73-4.55-2.39-0.24-0.71-14.58-7.12-35.07-16.29-0.18-0.24
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
0.091.891.831.420.932.84163.49-111.25-22.16-4.610.302.84
Price/Cash Flow ratio
-0.16-5.71-4.30-1.62-0.28-0.79-17.12-8.27-35.39-18.48-0.09-0.28
Price/Free Cash Flow ratio
-0.16-5.68-4.29-1.61-0.28-0.79-17.12-8.27-35.39-18.48-0.09-0.28
Price/Earnings Growth ratio
0.000.137.720.31-0.000.00N/A-0.080.580.410.00-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A0.57%-0.16%-1.04%-5.93%-29.37%0.13%0.09%8.63%10.41%N/A-5.93%
Return on Assets
-53.66%-30.23%-37.30%-42.96%-138.52%-264.17%-544.79%-160.78%-344.28%-393.90%-147.90%-147.90%
Return On Equity
-62.85%-33.05%-40.32%-59.50%-381.58%-398.33%-1121.34%1562.05%63.19%28.33%-201.84%-381.58%
Return on Capital Employed
-45.64%-34.35%-41.26%-55.77%-176.63%-455.06%-1121.34%-217.61%99.53%34.62%-165.28%-176.63%
Liquidity Ratios
Current Ratio
N/A20.2518.9510.824.142.96N/AN/AN/AN/A9.524.14
Quick Ratio
23.8319.7118.9510.313.772.961.913.580.200.078.303.77
Cash ratio
23.8319.7118.019.963.532.801.913.190.160.047.093.53
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/A11.68K5.76KN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A2.46K11.71K6.52K13.56KN/AN/AN/AN/AN/A13.56K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.14N/AN/AN/AN/AN/AN/A0.824.5011.560.10N/A
Debt Equity Ratio
0.17N/AN/AN/AN/AN/AN/A-8.00-0.82-0.830.11N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A1.14-0.17-0.06N/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A1.14-4.80-4.94N/AN/A
Interest Coverage Ratio
N/A-13.33-19.49-4.69-10.8916.30N/AN/AN/AN/AN/A-10.89
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/A-1.68-0.75-0.30N/AN/A
Company Equity Multiplier
1.171.091.081.382.751.502.05-9.71-0.18-0.071.111.50
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.001.0011110.9911
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-1.68-0.75-0.30N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-0.92-0.32N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A